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Introduction
Glucose-dependent insulinotropic polypeptide (GIP) is released by the entero-endocrine K cells from the proximal duodenum [1, 2] . GIP stimulates insulin secretion from pancreatic β-cells after ingestion of nutrients. GIP, together with Glucagon-like peptide 1 (GLP1), contributes for 50 to 70 percent to post-prandial insulin secretion [3] . GIP further enhances its glucose-lowering effects by the inhibition of hepatic glucose production and the stimulation of proinsulin gene transcription and translation. Moreover, GIP is known to play a role in lipid metabolism and fat deposition. Indeed, GIP increases lipoprotein lipase activity, stimulates lipogenesis, enhances fatty acid and glucose uptake in adipocytes [3] . GIP exerts its physiological functions through binding to GIP receptor (GIPR) which belongs to subfamily-2 of G-protein-coupled receptors (GPCR) [4, 5] . GIPR triggers Gs-mediated cAMP production and subsequent signaling cascades [3] .
Until very recently, one major argument against the development of a therapeutic strategy using GIP analogues to treat diabetes 2 was raised by the impairment of GIP-dependent insulin secretion in diabetic type II patients, with an almost complete loss of amplification of the second phase of insulin secretion [6] [7] [8] [9] [10] . This detrimental effect was found to result from down-regulation of GIPR presence in pancreatic β-cells exposed to diabetic milieu. Conversely, recent reports indicated that glycemia normalization in diabetic animals and humans significantly improves GIP-stimulated insulin secretion [11, 12] . Moreover, very promising pre-clinical data were obtained in rodents, monkeys and humans showing that a single peptidic molecule having dual agonist activity at GIP and GLP1 receptors exhibits enhanced insulinotropic and anti-hyperglycemic efficacy relative to GLP1 alone [13] . As a consequence, a renewed interest in developing pharmacological strategies to target GIPR has emerged [13] [14] [15] .
So far, regulation of GIPR presence at the cell surface remains poorly understood. First, although exposure of pancreatic islet cells to GIP has been shown to produce homologous desensitization of the GIP receptor, the impact of GIPR internalization and trafficking on GIPR-dependent response and the underlying molecular mechanisms have not been investigated in detail yet [16, 17] . Recently, it has been reported that in 3T3-L1 adipocytes, GIPR constitutively internalizes and recycles to the cell surface and that GIP induces a down-regulation of plasma membrane GIPR by slowing GIPR recycling without affecting kinetics of GIPR internalization [18] . Accordingly, GIPR does not conform to the typical behavior of G-protein coupled receptors which has been essentially studied for members of rhodopsin-related GPCRs (sub-family 1) and much less frequently for members of subfamily 2 of GPCRs such as the GIPR [19, 20] .
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In this context, the aim of this study was to investigate internalization of GIPR following agonist exposure, as well as cellular and molecular underlying mechanisms. Besides, this study enabled the identification of a GIP analogue, N-acetyl-GIP, so far recognized as a dipeptidyl-IV resistant GIP analogue, which fully stimulated cAMP production but with a ~15-fold lower potency than GIP. Furthermore, N-acetyl-GIP only weakly induced internalization of the GIPR and desensitization of GIPR-dependent cAMP response.
Materials and methods
Materials
Fragment 1-30 of human GIP (termed GIP) was synthesized as previously described [24] . N-acetyl-GIP(1-30) (termed N-acetyl-GIP) was from Millegen (Toulouse, France). Alexa Fluor 647 labeled-GIP (termed AlexaF647-GIP) and Alexa Fluor 647 labeled-acetyl-GIP(1-30) (termed AlexaF647-Nacetyl-GIP) were obtained according to the procedure described [24] . In both peptides, Alexa Fluor 647 moiety was coupled to the peptide and coupling products were HPLC purified. Peak corresponding to peptide in which Alexa Fluor 647 was attached to Lysine 30, as determined by Maldi Tof analysis, was selected [24] . Both fluorescent probes were highly specific of GIPR (less than 5% nonspecific labeling in the present of 100-fold excess of unlabeled peptide). Radio-labeled GIP was obtained by radio-iodination of Phe 1 -GIP(1-30) with 125 I-Na (Perkin Elmer, France) in the presence of chloramine T and was HPLC purified on a C-18 column. 125 University Medical Center, Durham, USA), was subcloned in pcDNA5/FRT. Plasmid encoding YFP tagged β-adaptin2 was given by Professor Michel Bouvier (Montreal University, Canada). All truncated receptor cDNAs at C-terminal tail (TR414, TR432 and TR452) and the GFP tagged GIPR constructs were obtained by insertion of a stop codon or linker sequence, respectively. All constructs were sequenced before use.
Cell lines and transfections
HEK 293 cells stably expressing the GIPR (Flp-ln TM HEK-GIPR) and the CCK2R (Flp-ln TM HEK-CCK2R) were obtained using the Flp-In TM system (Invitrogen). Alternatively, HEK293T transiently expressing the GIPR were used. All HEK293 derived cell lines cells were maintained in Dulbecco's Modified Eagle's medium supplemented with 10% of fetal bovine serum (FBS), in a humidified atmosphere at 95% air and 5% CO2. MIN-6-B1clone (kindly given by Doctor Jun-Ichi Miyazaki) was maintained in culture in Dulbecco's Modified Eagle's medium 25mM glucose supplemented with 15% of FBS, 71 µM 2-mercaptoethenol. Transfections were performed using polyethylenimine (PEI) transfection reagent (1mg/mL, pH 7.4) (Polyplus). Plasmids were diluted in DMEM without FBS (ratio DNA (µg) / PEI (µL) 1:3). The mixture was mixed for 15 sec on a vortex, incubated for 15 min at room temperature and then deposited on the cells.
Confocal fluorescence microscopy
Cells were plated onto poly-L-lysine (Sigma-Aldrich) coated 4-wells Lab-Tek chambered coverglass (Nunc). After an overnight growth, cells were transfected either with 1 µg/well of pcDNA5/FRT containing cDNAs of interest. 24 hours later, the culture medium was replaced by D-PBS (Dulbecco's PBS1X, 1mg/L glucose, 36mg/L sodium pyruvate, pH 7.4, calcium and magnesium free). Cells were stimulated with appropriate ligands and confocal microscopy images of GFP, DsRed or Alexa Fluor 647 fluorescence, were collected by using single-or double-line excitation (respectively 488 nm, 543nm, 633nm) on a Zeiss Laser Scanning Microscope LSM-510 or Zeiss Laser Scanning Microscope LSM-780 at 37°C. Concentrations of fluorescent GIP analogues equal or above 10 nM were used in internalization and trafficking studies because confocal microscopy and FACS did not enable detection of cell-associated fluorescence at lower concentrations. For β-arrestin1-GFP and β-arrestin2-GFP membrane recruitment assays, time series over a 5 min period were performed (pictures were taken every 30 seconds) and the decrease of cytoplasmic fluorescence was measured using the Region of interest (ROI) function of LSM-510 software.
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For recycling assay, cells were incubated with 100 nM GIP in DMEM/HEPES (20mM) for 1 hour at 37°C to enable GIPR internalization. Cells were washed 3 times with DMEM/HEPES and incubated without ligand for increasing times in order to enable GIPR recycling. GIPR at the cell surface were identified with AlexaF647-GIP (1µM) for 45 min at 37°C in the presence of the internalization inhibitor, dynasore (100 µM) added 5 min before the ligand.
BRET assays of β-arrestin recruitment and cAMP production
HEK 293T or Flp-In TM GIPR-293 cells were plated onto 10-cm culture dishes and overnight grown. For β-arrestin recruitment assays, cells were transfected with 0.2µg of Rluc tagged GIPR and 10µg of either β-arrestin1-YFP or β-arrestin2-YFP. For cAMP measurements, Flp-In TM GIPR-293 cells were transfected with 5µg of Epac biosensor. Alternatively, HEK 293T cells were co-transfected with 5 µg of Epac biosensor and 1 µg of GIP receptors. 24 hours after transfection, cells were plated in 96-wells clear bottom plates (Corning) at a density of 100.000 cells per well in phenol red free DMEM 2% FBS. After an overnight incubation, the medium was removed and replaced by calcium and magnesium free PBS. BRET assay was initiated by adding 10 µl of coelenterazine h to the wells (final concentration 5 µM). After 5 min of incubation with coelenterazine h, GIP, N-acetyl-GIP or Forskolin was added. Readings started 5 min after the addition of GIP or N-acetyl-GIP. A Mithras LB940 instrument (Berthold) that allows the sequential integration of signals at 465 to 505 nm and 515 to 555 nm windows and MicroWin 2000 software were used.
Receptor binding assays
Flp-In TM GIPR-293 cells grown overnight were onto 10-cm culture dishes. 24 h later, cells were transferred to 24-well plates. Approximately 24 h later, binding assays were performed using 125 I-Phe 1 -GIP according to the protocol previously described in detail [25] . Ki for competitors were calculated according to the equation Ki = IC 50 /1+[ 125 I-Phe 1 -GIP]/Kd ( 125 I-Phe 1 -GIP) in which IC 50 (concentration inhibiting half of specific binding) and Kd of 125 I-Phe 1 -GIP were calculated using the non-linear curve fitting software GraphPad Prism (San Diego, CA).
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Insulin secretion from MIN-6-B1cells
Insulinoma cells were seeded on 24-wells plates (3.10 5 cells/well) and let to grow for 48h. Cells were then washed 3-times with 500 µL KRBH buffer pH: 7.4 (125 mM NaCl, 4.74 KCl, 1 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 5mM NaHCO 3 , 10 mM, Hepes, 0.1% BSA). Cells were incubated for 2h at 37°C in KRH buffer supplemented with 2.8 mM glucose. The incubation medium was discarded and replaced with 500 µL buffer containing 11 mM glucose with or without GIP or Nacetyl-GIP. Cells were let to secrete insulin during 2h. Supernatants were centrifuged for 5 min at 2000 rpm to eliminate detached cells, and secreted insulin contained in supernatants was determined using Ultrasensitive Insulin Elisa Kit (Alpco) according to manufacturer instructions. Insulin secretion was expressed as -fold basal value obtained in the absence of GIP analogue.
Molecular modeling
The crystal structure of the human glucagon receptor (GCGR) with PDB code of 4L6R was used to build the homology model of the GIPR helical bundle using Prime 3.8 with the energy-based method [26] . The N-terminal domain of GIPR bound to GIP with PDB code of 2QKH was docked to the helical bundle taking into account the previously identified interactions between the N terminal domain of GIP and the residues of the GIPR helical bundle [24, 27] . The docking was done in two steps. Firstly, the first five amino acid residues of the N terminal domain was docked with the Induced Fit protocol, where docking was constrained around residues known to be important for binding from mutagenesis. Next, the remaining part of GIP together with the N terminal domain of GIPR was assembled manually and subjected to 500 ps minimization followed by 1000 ps of molecular simulations in implicit environment. MacroModel 9.9 was used for all minimizations and simulations.
Images with the molecular models were prepared with Maestro 9.9.
Statistics
All values are expressed as the mean +/-standard error of the mean (SEM). Statistical analyses of data using One-or two-way ANOVA with Dunnett's or Turkeys's comparison test were performed using GraphPad Prism version 6.0. In figures and table 1, significance degrees were given as following: * 0.01<p<0.05; ** 0.001<p<0.01; ***p<0.001 or 0.01<p<0.05; 0.001<p<0.01; p<0.001.
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GIP receptors rapidly and abundantly internalize following GIP stimulation
Flp-ln TM HEK-GIPR and HEK293T-GIPR cells used for studies of internalization and trafficking of GIPR were characterized prior to their use as biological tools. As shown on Supplemental figure 1S , cAMP levels measured by BRET using EPAC sensor were dose-dependently increased upon stimulation by GIP, with half-maximal stimulation (EC 50 ) in the nanomolar range. Therefore, GIPR appeared correctly coupled to adenylyl cyclase in the two cell lines. Moreover, cAMP production measured with EPAC sensor was in agreement with that measured using a radio-immunoassay [24] thus validating BRET assay to measure cAMP. We also characterized pharmacologically AlexaF647-GIP which was used to study internalization and intracellular trafficking of GIPR. As shown on supplemental Fig 1S and table 1 , alexaF647-GIP bound to Flp-ln TM HEK-GIPR cells and stimulated production of cAMP similarly to GIP. Moreover, fluorescence labeling of GIPR by alexaF647-GIP was highly specific since FACS analysis of Flp-ln TM HEK-GIPR cells incubated with alexaF647-GIP in the presence 1 µM unlabeled GIP revealed less than 5% of nonsaturable labeling (not illustrated).
Confocal microscopy observations of Flp-ln TM HEK-GIPR cells showed intense labeling of the plasma membrane immediately after addition of AlexaF647-GIP ( Fig. 1A ). Then, fluorescence was relocated in numerous membrane clusters and progressively penetrated into the cells as punctuate vesicles which formed clusters over the incubation time. Moreover, in HEKT293 transiently expressing GFP tagged GIPR, AlexaF647-GIP and GFP tagged GIPR co-localized during internalization and intracellular trafficking for at least 2 hours ( Fig. 1B ). This result establishes that internalized AlexaF647-GIP truly accounted for GIPR internalization. On the other hand, most of AlexaF647 and GFP fluorescence remained co-localized at time 5 hours, although some labeling appeared separately and GFP fluorescence intensity decreased likely because of degradation of GFP ( Fig. 1B) . Therefore, based on these controls and potential risks that GFP tag could hinder interactions between the intracellular region of GIPR and proteins of the endocytosis machinery, next experiments aimed at characterizing molecular mechanisms of GIPR internalization were carried out using AlexaF647-GIP to trace GIPR intracellular trafficking following internalization. It is worthy to mention that due to detection limits of confocal microscope and FACS, internalization and trafficking of the GIPR were investigated with concentrations of fluorescent probes equal or above 10 nM. Previous studies investigating GIPR targeting in vivo demonstrated GIPR internalization in response to picomolar concentrations of radiolabeled GIP [28] .
Quantification of the amount of internalized ligand resistant to acid-washing which efficiently 
Internalized GIP receptors poorly recycle and are mainly directed to lysosomes
The trafficking and fate of internalized GIPR was investigated in Flp-ln TM HEK-GIPR. Results from experiments designed to examine possible recycling of internalized GIPR at the cell surface showed a slight increase of GIPR density through recycling which however did not exceed 10-15% of initial GIPR population after 1 hour ( Fig. 2A ). Trafficking was examined in Flp-ln TM HEK transiently expressing both GFP tagged GIPR and fluorescent Rab proteins which are GTPases regulating intracellular trafficking between functionally distinct compartments in the cells [29] . Results showed early co-localization of internalized GIPR in Rab-5-positive early endosomes ( Fig. 2B ) and rare late co-localization in Rab-11 containing vesicles (Fig. 1C ). On the other hand, transport to lysosomes was evaluated using LysoTracker, an acidic organelle-selective fluorescent probes. Confocal microscopy images indicate that a part of AlexaF647-GIP labeled GIPR and GIPR-GFP co-localized in lysoTracker-labeled lysosomes at 30 min and that almost the totality of internalized labeled GIP receptors were found in lysosomes at times 2 and 3 h ( Fig. 2C ).Together, these data demonstrate that GIPR receptors rapidly internalize upon GIP stimulation and are mostly directed to lysosomal degradation pathway, with only a minority of receptors recycling to the cell surface.
Internalization of GIP receptor involves clathrin-coated pits and dynamin
Internalization of GPCRs can occur through two main membrane structures, caveolae and clathrincoated pits [21, 30] . The role of clathrin in GIPR internalization was investigated by expressing a GFP incubation as long as 1h, most of the AlexaF647-labeled GIPR remained at the cell surface and a minority of labeled GIPR was internalized ( Fig. 3C ). These images clearly indicate that dynamin is required for the internalization of GIPR.
Internalization of the GIP receptor does not require β-arrestins nor C-terminal region of the receptor but involves AP-2
Most often, the cascade of molecular events in the process of GPCR internalization through clathrin-coated pits involves the phosphorylation by GRK of Ser/Thr residues located on extreme Cterminal region and/or intracellular loops of receptors and subsequent binding of β-arrestins which play a role of adaptor for receptor binding to both β2-subunit of AP-2 complex and clathrin [20] .
The possible involvement of β-arrestins in GIPR internalization was examined. We first determined whether GIPR recruited β-arrestins using confocal microsopy and BRET, the later being recognized as a highly sensitive biophysical assay for detection of protein proximity [31] . Results showed no change in the concentration of cytoplasmic GFP tagged β-arrestin1 or 2 following GIP stimulations ( BRET signal was seen with CCK2R, as previously documented [32] . Absence of β-arrestin1/2 recruitment by GIPR was observed in confocal microscopy and BRET experiments with ratio of transfected plasmids ranging from 1:10 to 10:1. Collectively, these results indicate that GIPR most likely internalizes without requiring β-arrestin1 or 2 recruitment.
We then evaluated the involvement of the C-terminal region of GIPR by constructing truncated GIPR. The GIPR constructs were first tested for their ability to stimulate adenylyl cyclase in response to GIP. As shown on supplemental Fig. 5SA , truncated GIPR at residues 414, 432 or 452 responded to GIP stimulations by increasing cAMP levels to the same maximum as the wild-type GIPR. However, half-maximal stimulation of GIPR-TR414 or GIPR-TR432 required higher GIP concentrations than did the wild-type GIPR (EC 50 : 5.2 ± 0.1 nM or 5.8 ± 0.1 nM versus 0.27 ± 0.21 nM, respectively) suggesting importance of the eliminated part of the receptor C-terminal tail for Gs coupling. Confocal microscopy observations indicate that abundant internalization could be seen in cells expressing the different truncated GIPR (Supplemental Fig. 5S, B ). Quantification of internalization of these truncated GIPR using acid-washing showed no significant differences (Supplemental Fig. 5S , C).
Therefore, none of the amino acids from C-terminal tail of GIPR seems to be essential for internalization, thus confirming previous data with rat GIPR [33] .
Finally, the involvement of AP-2 in GIPR internalization was investigated by co-expressing YFP tagged β 2 -subunit of AP-2 in Flp-ln TM HEK-GIPR cells. Imaging results show abundant co-localization
between β 2 -subunit of AP-2 and AlexaF647-labeled GIPR strongly suggesting participation of AP-2 complex to the internalization machinery of the GIPR (Fig. 4B ).
N-acetylation of GIP affects activity of the peptide on cAMP production, GIPR internalization and GIPR desensitization
Structure-activity relationship data with GIP as well as mapping of GIP binding site in GIPR demonstrated that N-terminal region of GIP is essential for its biological activity [24, 34, 35] . On the other hand, N-terminal modifications of GIP were reported to increase resistance of GIP to degradation by DPP IV and/or its efficacy as an incretin [34, 36] . We therefore tested whether N-acetyl modification of GIP affects ability of the peptide to trigger internalization and desensitization of the GIPR.
We first determined affinity of N-acetyl-GIP for human GIPR by performing binding experiments.
Results show that N-acetyl-GIP competed with radio-iodinated GIP to GIPR with ~2.5-fold lower affinity than that of GIP (Ki : 28.6 and table 1), supporting again that N-acetyl moiety is more important for GIPR activation than for ligand binding.
Confocal microscopy studies of GIPR internalization following stimulation with 1 µM AlexaF647-N-acetyl-GIP showed minor internalization as compared with 0.1 µM AlexaF647-GIP which provided similar cAMP production levels (Fig. 5C ). In agreement with this result, unlabeled N-acetyl-GIP did significantly stimulate internalization of GFP tagged GIPR transiently expressed in HEK 293T cells, thus ruling out a possible role of AlexaF647 moiety in the inability of N-acetyl-GIP to trigger GIPR internalization ( Fig. 5C ). Furthermore, using acid-washing procedure, we quantified internalization of than that of AlexaF647-GIP at the three concentrations tested. Despite no EC 50 could be calculated because dose-response curves did not reach a plateau, data from acid-washing experiments support that AlexaF647-N-acetyl-GIP and AlexaF647-GIP stimulate differently trapping and/or internalization of the GIPR. Strikingly, between ~54 and ~75% of cell-associated AlexaF647-N-acetyl-GIP were resistant to acid-washing whereas only a minority of fluorescence was detected in the cell interior by confocal microscopy. This apparent discrepancy suggests that binding of AlexaF647-N-acetyl-GIP to GIPR was rapidly followed by its trapping (or sequestration) at the plasma membrane but this was not pursued by its complete internalization.
In light of the data showing distinct abilities of AlexaF647-N-acetyl-GIP and AlexaF647-GIP to stimulate GIPR internalization, we compared desensitization of cAMP responses stimulated with Nacetyl-GIP or GIP. Indeed, phosphorylation by second messenger-dependent protein kinases and Gprotein-coupled receptor kinases (GRK) followed by internalization are major cause of desensitization of GPCR signaling [19, 20] . For desensitization experiments, Flp-ln TM HEK-GIPR cells were prestimulated with N-acetyl-GIP or GIP for different periods of time in order to cause desensitization of GIPR response. Then, cAMP production in response to a second agonist challenge was measured. As shown on Fig. 7 , pre-stimulations with GIP dramatically decreased the ability of GIPR to respond to a second agonist challenge. Indeed, a 15-minute pre-stimulation decreased by 63% the cAMP response to GIP. In contrast, 15-minutes pre-stimulation of the cells with N-acetyl-GIP did not significantly affect cAMP responses; Neither GIP, nor N-acetyl-GIP pre-stimulation affected the ability of forskolin to increase cAMP level indicating that desensitization of cAMP responses was related to GIPR and not to adenylyl cyclase (not shown). Finally, PKA inhibitor, H89, which did not significantly affect internalization (Supplemental Fig. 7S ) only partially reversed down regulation by GIP and entirely reversed N-acetyl-GIP-induced desensitization of cAMP response. In summary, N-acetyl-GIP differs from GIP mostly in its potency to stimulate cAMP production, as well as in its ability to desensitize GIPR-induced cAMP production and to stimulate GIPR internalization.
N-acetyl-GIP efficiently stimulates insulin secretion from MIN-6 cells.
We next compared stimulatory effects of GIP and N-acetyl-GIP on cultured β-cells. As shown on 
Discussion
In the context of a renewed interest for the development of GIP analogues therapeutic value, the aim of the current study was to investigate internalization of the GIPR following pharmacological stimulation by agonists, as well as the cellular and molecular underlying mechanisms. This study was carried out in HEK cells, a reference cell model for internalization studies. The molecular events linking GIPR activation and its subsequent targeting to clathrin-coated pits were also investigated. Several lines of evidence support that GIPR internalization does not require βarrestins. First, both confocal microscopy and BRET studies were unable to show recruitment of βarrestin 1 or 2 whereas parallel experiments showed this recruitment to the CCK2R used as a reference receptor recruiting β-arrestins [32] . Moreover, elimination of phosphorylatable amino acids by truncation of C-terminal region of GIPR did not affect internalization of the GIPR, a result in agreement with previous reports by others showing that, although probably phosphorylated on two serines, the C-terminal tail of rodent GIPR was not essential for agonist-induced internalization [33, 40] . Moreover, our results agree with those reported during the preparation of this manuscript, indicating no significant recruitment β-arrestin2 by the GIPR in HEK293 cells [41] . On the other hand, confocal microscopy observations strongly support participation of the AP-2 complex in GIPR internalization, a result in line with evidence showing that AP-2 is essential, if not required, in clathrin-coat pit formation [42, 43] . β-arrestins are adaptor proteins classically recruited by phosphorylated G-protein coupled receptors, a biochemical event that is followed by binding of receptor-arrestin dimer to both β2-subunit of the AP-2 complex and clathrin, and subsequent targeting of the resulting cargo to clathrin-coated pits. The fact that GIPR internalization does not require βarrestins whereas it involves AP-2 raises the question of the mechanism by which activated GIPR is [21] . Several G-protein-coupled receptors, such as protease-activated receptor 1 (PAR1), the chemokine CXCR2 and CXCR4 receptors, and the β2adrenergic receptor have been shown to internalize by involving such sorting motifs [44] [45] [46] [47] . We have performed an analysis of amino acid sequence of the GIPR and found 3 potential consensus sorting motifs in the intracytosolic region of the protein (bottom of transmembrane segments 2, 4 and 7). However, point-mutations within these motifs did not affect significantly GIPR internalization (unpublished data). Among other likely hypotheses, involvement of GPCR kinases (GRKs) is plausible. GRK are best known to phosphorylate intracellular domains of active GPCRs resulting in receptor desensitization and internalization and are also capable of regulating GPCR signaling and trafficking independently of phosphorylation [48] [49] [50] . GRK2 has been shown to directly interact with clathrin through a clathrin box [48] [49] [50] . However, contradictory results were reported about interaction of GRK2 with GIPR [40, 41] . Indeed, recruitment assay using FRET could not detect any binding of GRK2 to the GIPR whereas GRK2 over-expression caused drops in GIPR-dependant cAMP production and insulin secretion [40, 41] .
An additional important finding of the current work is the identification of new pharmacological properties of N-acetyl-GIP. This peptide was previously shown to have an improved antihyperglycemic activity and stimulatory action on insulin secretion in vivo in ob/ob mice [51] . The half-life of N-acetyl-GIP to DPP IV degradation was estimated to be >24 hours in plasma versus 6.2 hours for natural GIP [52] . In the current study, N-acetyl-GIP was found to be as potent and efficient as GIP to stimulate insulin secretion from MIN-6-B1 cells in spite of its 15-fold lower potency to stimulate cAMP production. These findings must be examined in light of results showing that Nacetyl-GIP incompletely stimulates GIPR endocytosis and displays a decreased ability to desensitize GIP-induced cAMP production. It is thus plausible that N-acetylation of GIP improves insulinotropic action of the peptide by decreasing its potency to stimulate desensitization, internalization and lysosomal degradation of the GIPR. Additionally, like several other G-protein coupled receptors, GIPR might stimulate cAMP production from plasma membrane and early endocytosis vesicles as well and both cAMP pools would contribute to insulin secretion [53] . Related to this hypothesis, it will be important to investigate precise early trafficking of GIPR stimulated both by GIP and N-acetyl-GIP, as well as possible differential effects of the two peptides on GIPR recycling.
Thus, N-acetylation has a minor impact on affinity of GIP for its receptor but more strongly affects ability of GIP to activate GIPR. These findings are compatible with converging data showing that Nterminal part of GIP is crucial for activation of the GIPR, whereas the C-terminal region of GIP is essentially involved in ligand binding [24, 34, 35, 37] . Also, our previous studies dedicated to mapping of the activation site of the GIPR showed that N-terminus of receptor-bound GIP is in contact with aminoacids from transmembrane domains of the GIPR [24] . Our results showing distinct behaviors of N-acetyl-GIP relative to the full agonist GIP led us to examine if this could be explained by different binding poses of the two ligands in the binding site of the modeled GIPR. We previously identified M A N U S C R I P T
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14 amino acid residues of the GIPR binding site that are essential for GIPR activation by GIP using an iterative approach involving homology modeling based on templates of Group A GPCRs and sitedirected mutagenesis [24] . For the purpose of this study, we have validated the data by reconstructing the GIPR homology model using the recently published crystal structure of the human glucagon receptor (GCGR), a Group B GPCR having a sequence identity of 58% with GIPR. In the modeled GIPR.GIP complex represented in Fig. 9A and B , the side chain of Tyr1 in GIP forms a H-bond with Q224 and a cation-π interaction with R300 and the terminal ammonium moiety of Tyr1 has an ionic interaction with E377 and a cation-π interaction with F357. The side chain of Glu3 forms an ionic interaction with R183. The backbone of Gly4 forms a H-bond with R190. The importance of R183, R190, Q224, R300 and F357 in GIPR activation by GIP agrees with earlier site-directed mutagenesis results [24] . Docking of N-acetyl-GIP in the binding site of the GIPR indicates that N-acetyl-GIP maintains the most of contacts apart from interactions with E377 and F357, acetylated nitrogen being moved away from these residues (Fig. 9C) . As a consequence, N-acetyl-GIP has a less number of interactions with helices 6 and 7 compared to GIP. These results, together with data showing that helices 6 and 7 in G-protein coupled receptors are essential for stabilization of the active conformation of receptors, may explain atypical activity of N-acetyl-GIP analogue [37] [38] [39] . So, it is plausible that the two agonists may stabilize different conformations of the GIPR, each of which having distinct ability to trigger signals.
The understanding of the origin of incomplete internalization and decreased desensitization of GIPR following stimulation by N-acetyl-GIP will deserve additional investigations. Meanwhile, the fact that the PKA inhibitor fully reverses desensitization by N-acetyl-GIP whereas it partly reverses that by GIP supports the view that distinct signaling pathways and mechanisms cause desensitization of GIPR response: weak desensitization following N-acetyl-GIP exposure would mainly involve cAMP-dependent protein kinase (PKA) whereas more intensive desensitization by GIP would involve both PKA and other signaling pathways, including those leading to internalization. Thus, it is plausible that N-acetyl-GIP fails to activate a step of GIPR signaling involved in both desensitization and internalization. Accordingly, N-acetyl-GIP is a biased agonist candidate.
Our results on GIPR internalization in HEK cells differ from those recently reported in transfected 3T3L1 adipocytes [18] . In the last study, it was shown that GIPR constitutively internalizes and recycles to the cell surface and GIP regulates down-regulation of plasma membrane GIPR by slowing GIPR recycling without affecting kinetics of GIPR internalization [18] . We have no explanation for such different findings excepted that GIPR, like other G-protein coupled receptors, could behave differently according to the cell context [54] . On the other hand, it is interesting to compare behavior of the GIPR with that of the GLP1R. Indeed, although these two receptors are highly homologous in structure and functions, their insulinotropic responses are differently affected in diabetics. Studies insulinoma and HEK cells both showed that GLP1 rapidly internalizes in response to its natural agonist but also rapidly recycles to the cell surface [55, 56] . Furthermore, GLP1 was shown to recruit M A N U S C R I P T
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GRK2 and β-arrestin2 upon activation [41] . Thus, with respect to recycling to the cell surface and molecular mechanisms involved in internalization, GIPR seems to differ from GLP-1R [41, 55, 56] .
Conclusion
In this study, internalization of the GIPR and subsequent intracellular trafficking has been characterized. GIP stimulated rapid robust internalization of the GIPR, the major part being directed to lysosomes. GIPR internalization involved clathrin-coated pits, AP-2 and dynamin. However, neither GIPR C-terminal region nor β-arrestin1/2 was required. Thus, mechanisms of GIPR internalization seems to differ from that reported for GLP1R. Finally, N-acetyl-GIP recognized as a dipeptidyl-IV resistant analogue appeared to weakly stimulate GIPR internalization and desensitization of cAMP response. Molecular modelingof GIPR.N-acetyl-GIP complex enabled to show that N-acetyl-GIP interact more slightly with amino acids of helices 6 and 7 of the GIPR compared to GIP, supporting that the two agonists may stabilize different conformations of the GIPR, each of which having distinct ability to trigger signals. We propose that incomplete or partial activity of N-acetyl-GIP on signaling involved in GIPR desensitization and internalization contributes to the enhanced incretin activity of this peptide which is a biased agonist candidate.
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only reversed a fraction of GIP-induced desensitization of cAMP production whereas it fully reversed N-acetyl-GIP-induced desensitization of cAMP production. The absence of effect of H89 on GIP-induced GIPR internalization was confirmed by acid-washing experiment which indicated that the same amount of AlexaF647-GIP was resistant to acid washing when internalization proceeded in the absence or in the presence of H89.
